Compare BNR & FMN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | BNR | FMN |
|---|---|---|
| Founded | 2014 | 2002 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Medical Specialities | Investment Managers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 94.4M | 88.7M |
| IPO Year | 2019 | N/A |
| Metric | BNR | FMN |
|---|---|---|
| Price | $9.40 | $11.12 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 15.1K | ★ 28.4K |
| Earning Date | 06-05-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 3.86% |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $111.65 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $5.31 | $10.41 |
| 52 Week High | $41.72 | $11.76 |
| Indicator | BNR | FMN |
|---|---|---|
| Relative Strength Index (RSI) | 46.02 | 32.27 |
| Support Level | $8.34 | $11.00 |
| Resistance Level | $10.00 | $11.33 |
| Average True Range (ATR) | 0.78 | 0.11 |
| MACD | -0.01 | -0.04 |
| Stochastic Oscillator | 17.10 | 6.22 |
Burning Rock Biotech Ltd is a cancer diagnostics company. The Group provides pharma research and development services, mainly cancer therapy selection tests services, companion diagnostics development services, and other service agreements with the combination of various customized tests services and analytical validation services, to pharmaceutical companies for developing new drugs for targeted therapies, immunotherapies on various types of cancers, and to hospitals for their studies on cancer diagnosis & treatment. It had three operating segments, including the Central laboratory business, the In-hospital business, & Pharma research & development services. It generates the majority of its revenue from the Central laboratory business. Its products are Pan-HEME, OncoScreen-WES, & others.
Federated Hermes Premier Municipal Income Fund is a United States-based diversified, closed-end management investment company. The investment objective of the fund is to provide current income exempt from federal income tax, including the federal alternative minimum tax by investing in long-term, tax exempt municipal bonds diversified among states, sectors and issuers. Its portfolio of investments comprises different sectors such as hospitals, toll road, senior care, airport, tobacco, and other sectors.